NCT04480151View on ClinicalTrials.gov

ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

April 21, 2021

Study Completion Date

April 21, 2021

Conditions
Cardiogenic ShockEnd-stage Heart Failure
Interventions
OTHER

standard of care

retrospective study: standard of care

Trial Locations (5)

21079

CHU de Dijon-Bourgoigne, Dijon

31059

CHU de Toulouse, Toulouse

33604

CHU de Bordeaux, Pessac

34295

CHU de Montpellier, Montpellier

35000

CHU de Rennes, Rennes

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04480151 - ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD) | Biotech Hunter | Biotech Hunter